Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Akeso Biopharma Inc (9926 HK)
Watchlist
211
Analysis
Health Care
•
China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Antengene
•
10 Nov 2020 16:38
Antengene IPO: Valuation Insights
Antengene has launched an HK IPO to raise net proceeds of $318 million at the mid-point of the price range. Overall, strong cornerstones and our...
Arun George
Follow
374 Views
Share
bullish
•
Antengene
•
10 Nov 2020 00:55
Antengene: We Like the Deal
This Insight recommends participating in the IPO of Antengene considering the proposed valuation and market opportunity.
Kemp Dolliver, CFA
284 Views
Share
bullish
•
Remegen
•
08 Nov 2020 09:57
A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation...
Xinyao (Criss) Wang
Follow
353 Views
Share
bullish
•
Antengene
•
06 Nov 2020 07:40
Antengene: Gunning To Move Up in Line
This Insight provides an in-depth review of pre-revenue biotechnology Antegene that plans to list on the HKEX. We discuss the pipeline, market...
Kemp Dolliver, CFA
464 Views
Share
bullish
•
Everest Medicines
•
24 Oct 2020 23:47
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
Kemp Dolliver, CFA
346 Views
Share
First
Previous
31
32
33
34
35
36
37
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x